{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T05:43:58Z","timestamp":1769319838474,"version":"3.49.0"},"reference-count":32,"publisher":"Hindawi Limited","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1321,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1111\/j.1742-1241.2011.02837.x","type":"journal-article","created":{"date-parts":[[2012,1,19]],"date-time":"2012-01-19T07:14:51Z","timestamp":1326957291000},"page":"199-209","source":"Crossref","is-referenced-by-count":60,"title":["Effect of teriparatide on bone mineral density and fracture in postmenopausal osteoporosis: meta-analysis of randomised controlled trials"],"prefix":"10.1155","volume":"66","author":[{"given":"S.-L.","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.-L.","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2012,1,19]]},"reference":[{"key":"10.1111\/j.1742-1241.2011.02837.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jama.285.6.785","article-title":"Osteoporosis prevention, diagnosis, and therapy","volume":"85","author":"NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy","year":"2001","journal-title":"JAMA"},{"key":"10.1111\/j.1742-1241.2011.02837.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1359\/jbmr.1998.13.5.763","article-title":"A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men","volume":"13","author":"Riggs","year":"1998","journal-title":"J Bone Miner Res"},{"key":"10.1111\/j.1742-1241.2011.02837.x-BIB3|cit3","first-page":"551","article-title":"The cost of treating osteoporotic fractures in the United Kingdom female population","volume":"11","author":"Johansen","year":"2000","journal-title":"Osteoporos Int"},{"key":"10.1111\/j.1742-1241.2011.02837.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/gme.0b013e3181c617e6","article-title":"Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society","volume":"17","author":"Anonymous","year":"2010","journal-title":"Menopause"},{"key":"10.1111\/j.1742-1241.2011.02837.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1210\/er.2001-9002","article-title":"Summary of meta-analyses of therapies for postmenopausal osteoporosis","volume":"23","author":"Cranney","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1111\/j.1742-1241.2011.02837.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1001\/archinte.164.18.2024","article-title":"Sustained vertebral fracture risk reduction after withdrawal of teriparatide in postmenopausal women with osteoporosis","volume":"164","author":"Lindsay","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1742-1241.2011.02837.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1210\/en.132.4.1577","article-title":"The effect of recombinant human (1-84) or synthetic human (1-34) parathyroid-hormone on the skeleton of adult osteopenic ovariectomized rats","volume":"132","author":"Kimmel","year":"1993","journal-title":"Endocrinology"},{"key":"10.1111\/j.1742-1241.2011.02837.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2011.02837.x-BIB9|cit9","unstructured":"Higgins J Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1. 0 The Cochrane Collaboration 2011"},{"key":"10.1111\/j.1742-1241.2011.02837.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1111\/j.1742-1241.2011.02837.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/01926230252929882","article-title":"Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety","volume":"30","author":"Vahle","year":"2002","journal-title":"Toxicol Pathol"},{"key":"10.1111\/j.1742-1241.2011.02837.x-BIB12|cit12","doi-asserted-by":"crossref","DOI":"10.1002\/9780470743386","volume-title":"Introduction to Meta-Analysis","author":"Borenstein","year":"2009"},{"key":"10.1111\/j.1742-1241.2011.02837.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1111\/j.1742-1241.2011.02837.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1359\/jbmr.2001.16.5.925","article-title":"Parathyroid hormone added to established hormone therapy: effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal","volume":"16","author":"Cosman","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1111\/j.1742-1241.2011.02837.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1056\/NEJMoa050157","article-title":"Daily and cyclic parathyroid hormone in women receiving alendronate","volume":"353","author":"Cosman","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2011.02837.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1359\/JBMR.051020","article-title":"Effect of teriparatide [rhPTH(1-34)] on BMD when given to postmenopausal women receiving hormone replacement therapy","volume":"21","author":"Ste-Marie","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1111\/j.1742-1241.2011.02837.x-BIB17|cit17","first-page":"418","article-title":"Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis - an Indian experience","volume":"56","author":"Sethi","year":"2008","journal-title":"J Assoc Physicians India"},{"key":"10.1111\/j.1742-1241.2011.02837.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/s00774-008-0871-3","article-title":"Effect of teriparatide on bone mineral density and biochemical markers in Japanese women with postmenopausal osteoporosis: a 6-month dose-response study","volume":"26","author":"Miyauchi","year":"2008","journal-title":"J Bone Miner Metab"},{"key":"10.1111\/j.1742-1241.2011.02837.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1210\/jc.2009-1703","article-title":"Effects of teriparatide, alendronate, or both in women with postmenopausal osteoporosis","volume":"95","author":"Finkelstein","year":"2010","journal-title":"J Clin Endocr Metab"},{"key":"10.1111\/j.1742-1241.2011.02837.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1210\/jc.2009-0358","article-title":"Effect of transdermal teriparatide administration on bone mineral density in postmenopausal women","volume":"95","author":"Cosman","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2011.02837.x-BIB21|cit21","first-page":"1","article-title":"Dietary intake of selected minerals for the United States population: 1999-2000","author":"Ervin","year":"2004","journal-title":"Adv Data"},{"key":"10.1111\/j.1742-1241.2011.02837.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7326\/0003-4819-148-3-200802050-00198","article-title":"Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis","volume":"148","author":"MacLean","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1742-1241.2011.02837.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1590\/S1516-31802008000500007","article-title":"Teriparatide (recombinant human parathyroid hormone 1-34) in postmenopausal women with osteoporosis: systematic review","volume":"126","author":"Trevisani","year":"2008","journal-title":"Sao Paulo Med J"},{"key":"10.1111\/j.1742-1241.2011.02837.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00198-006-0204-0","article-title":"Effects of parathyroid hormone alone or in combination with antiresorptive therapy on bone mineral density and fracture risk - a meta-analysis","volume":"18","author":"Vestergaard","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1111\/j.1742-1241.2011.02837.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1210\/er.2004-0006","article-title":"Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use","volume":"26","author":"Hodsman","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1111\/j.1742-1241.2011.02837.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"c3691","DOI":"10.1136\/bmj.c3691","article-title":"Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis","volume":"341","author":"Bolland","year":"2010","journal-title":"BMJ"},{"key":"10.1111\/j.1742-1241.2011.02837.x-BIB27|cit27","article-title":"Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women\u2019s Health Initiative limited access dataset and meta-analysis","volume":"342","author":"Reid","year":"2011","journal-title":"Brit Med J"},{"key":"10.1111\/j.1742-1241.2011.02837.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s001980170006","article-title":"Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds","volume":"12","author":"Kanis","year":"2001","journal-title":"Osteoporos Int"},{"key":"10.1111\/j.1742-1241.2011.02837.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.bone.2003.12.022","article-title":"Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy","volume":"34","author":"Delmas","year":"2004","journal-title":"Bone"},{"key":"10.1111\/j.1742-1241.2011.02837.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1210\/jc.2008-0353","article-title":"Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate","volume":"93","author":"Miller","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2011.02837.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1359\/jbmr.080506","article-title":"Effects of two years of daily teriparatide treatment on BMD in postmenopausal women with severe osteoporosis with and without prior antiresorptive treatment","volume":"23","author":"Obermayer-Pietsch","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1111\/j.1742-1241.2011.02837.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2288-5-14","article-title":"The strengths and limitations of meta-analyses based on aggregate data","volume":"5","author":"Lyman","year":"2005","journal-title":"BMC Med Res Methodol"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2011.02837.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1742-1241.2011.02837.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:04:03Z","timestamp":1643349843000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-1241.2011.02837.x"}},"subtitle":["Effect of teriparatide in postmenopausal osteoporosis"],"short-title":[],"issued":{"date-parts":[[2012,1,19]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1742-1241.2011.02837.x","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1,19]]}}}